CORDA Investment Management LLC. Increases Holdings in Kenvue Inc. (NYSE:KVUE)

CORDA Investment Management LLC. grew its holdings in Kenvue Inc. (NYSE:KVUE) by 1.4% during the fourth quarter, according to the company in its most recent filing with the SEC. The fund owned 1,253,096 shares of the company’s stock after acquiring an additional 17,466 shares during the quarter. Kenvue comprises 2.1% of CORDA Investment Management LLC.’s investment portfolio, making the stock its 24th biggest holding. CORDA Investment Management LLC.’s holdings in Kenvue were worth $26,754,000 as of its most recent SEC filing.

A number of other hedge funds have also made changes to their positions in the business. Grove Bank & Trust grew its holdings in shares of Kenvue by 438.4% during the fourth quarter. Grove Bank & Trust now owns 1,163 shares of the company’s stock worth $25,000 after purchasing an additional 947 shares during the last quarter. Geneos Wealth Management Inc. acquired a new stake in shares of Kenvue in the 4th quarter valued at about $29,000. Fortitude Family Office LLC grew its stake in Kenvue by 106.6% during the 4th quarter. Fortitude Family Office LLC now owns 1,506 shares of the company’s stock worth $32,000 after buying an additional 777 shares during the last quarter. Ashton Thomas Securities LLC acquired a new position in Kenvue during the third quarter worth approximately $35,000. Finally, Versant Capital Management Inc lifted its stake in Kenvue by 300.8% in the fourth quarter. Versant Capital Management Inc now owns 1,920 shares of the company’s stock valued at $41,000 after buying an additional 1,441 shares during the last quarter. Hedge funds and other institutional investors own 97.64% of the company’s stock.

Analyst Upgrades and Downgrades

KVUE has been the topic of a number of research reports. Citigroup lowered their target price on shares of Kenvue from $25.00 to $21.00 and set a “neutral” rating on the stock in a research report on Wednesday, January 15th. Deutsche Bank Aktiengesellschaft lowered shares of Kenvue from a “buy” rating to a “hold” rating and dropped their price objective for the company from $25.00 to $24.00 in a research note on Thursday, December 12th. UBS Group decreased their target price on shares of Kenvue from $23.00 to $21.00 and set a “neutral” rating for the company in a research note on Friday, February 7th. Piper Sandler raised their price target on Kenvue from $24.00 to $27.00 and gave the stock an “overweight” rating in a report on Monday. Finally, Canaccord Genuity Group reduced their price objective on Kenvue from $27.00 to $24.00 and set a “buy” rating for the company in a research note on Friday, February 7th. One analyst has rated the stock with a sell rating, eight have assigned a hold rating and five have issued a buy rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of “Hold” and an average price target of $23.08.

Kenvue Trading Down 0.3 %

NYSE:KVUE opened at $23.15 on Friday. Kenvue Inc. has a 1 year low of $17.67 and a 1 year high of $24.46. The company has a debt-to-equity ratio of 0.66, a quick ratio of 0.69 and a current ratio of 1.00. The stock has a fifty day moving average price of $21.42 and a two-hundred day moving average price of $22.24. The stock has a market capitalization of $44.24 billion, a price-to-earnings ratio of 43.67, a PEG ratio of 2.62 and a beta of 1.45.

Kenvue (NYSE:KVUE) last announced its quarterly earnings results on Thursday, February 6th. The company reported $0.26 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $0.26. Kenvue had a net margin of 6.66% and a return on equity of 20.97%. As a group, sell-side analysts anticipate that Kenvue Inc. will post 1.14 earnings per share for the current fiscal year.

Kenvue Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Wednesday, February 26th. Stockholders of record on Wednesday, February 12th were paid a dividend of $0.205 per share. This represents a $0.82 annualized dividend and a dividend yield of 3.54%. The ex-dividend date of this dividend was Wednesday, February 12th. Kenvue’s dividend payout ratio (DPR) is 154.72%.

Kenvue Profile

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.